|
|
 | | | |
- close
- close
- close
- close
QUOTE AND NEWS
Benzinga
Apr 18
Comment
Spherix Incorporated (NASDAQ: SPEX) today announced results from its recently completed studies using near-infrared spectroscopy on autopsy samples from humans who had confirmed cardiovascular disease. Results showed that these atherosclerotic...
Apr 18
Comment
We recommend investors keep an eye on Spherix, Inc. (SPEX). The stock has a history of quick rallies on news, followed by quick sell-offs on subsequent dilutive financings. The company has several catalysts coming up over the next few quarters...
PR Newswire
Apr 10
Comment
BETHESDA, Md., April 10, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) - an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food,
PR Newswire
Mar 28
Comment
BETHESDA, Md., March 28, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) - an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food,
Benzinga
Mar 8
Comment
Below are highlights from Benzinga's daily coverage of microcap securities making big moves:
Spherix Incorporated
Shares of Spherix Incorporated (NASDAQ: SPEX), the Bethesda, MD developer of pharmaceutical products, rose 21% Wednesday on 24...
Benzinga
Mar 7
Comment
Spherix Incorporated (NASDAQ: SPEX) – today announced that one of its drug candidates, SPX-106T, arrested development and reduced atherosclerotic plaque area in the aortic arch, thoracic aorta and sinus of Valsalva in mice genetically...
OilVoice
Feb 13
Comment
During the period the firm39s overall turnover increased from pound2.1million recorded in 2010 to pound7.5million. SPEX39 acquisition of Third Party Services TPS in 2011 played a key
Benzinga
Jan 11
Comment
Shares of Spherix (NASDAQ: SPEX) Inc are up more than 31% today after the company announced a successful completion of a toxicology study.
Results demonstrated an ample margin of safety with the dosing planned for the first-in-human study. The...
StreetInsider.com
Nov 4
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Spherix+%28SPEX%29+Files+1.06M+Common+Shelf+for+Selling+Shareholders/6916787.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
